Trademark Overview
On Tuesday, April 9, 2024, a trademark application was filed for OCYNTIO with the United States Patent and Trademark Office. The USPTO has given the OCYNTIO trademark a serial number of 98491066. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 9, 2024. This trademark is owned by Actelion Pharmaceuticals Ltd. The OCYNTIO trademark is filed in the Pharmaceutical Products category with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines.